June 20, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biopharmaceutical company developing sulfur-based therapeutics for rare ...

The exposure to ultraviolet rays successfully created a new strain, DLac_Mut2_221, that produces approximately 1.5 times more D-lactic acid. "Further, we performed genetic analyses using ...

Detailed price information for Thiogenesis Therapeutics Corp (TTI-X) from The Globe and Mail including charting and trades.

Clinical Investigation Published: September 2009 Article Lactic Acidosis in a Newborn With Adrenal Calcifications Alexandra Zecic, Joél E Smet, Claudine M De Praeter, Piet Vanhaesebrouck, Carlo ...

Introduction: Myopathy, encephalopathy, lactic acidosis, and stroke-like (MELAS) syndrome, a maternally inherited disorder that is among the most common mitochondrial DNA (mtDNA) diseases, is usually ...